Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G MOERTEL

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Cancer|March 1, 1976
A phase I study of cytembenaS Frytak, C G Moertel, A J Schutt, et al.
Journal of Surgical Oncology|July 1, 1982
Human colorectal carcinoma: patterns of sensitivity to chemotherapeutic agents in the human tumor stem cell assayM V Agrez, J S Kovach, R W Beart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinomaC G Moertel, D S Childs, J R O'Fallon, et al.
JAMA|February 13, 1981
A pharmacologic and toxicological study of amygdalinC G Moertel, M M Ames, J S Kovach, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987
Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy patternN A Scott, H S Wieand, C G Moertel, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
International Journal of Cancer|August 15, 1978
A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levelsA Shani, R E Ritts, G S Thynne, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Annals of Internal Medicine|August 1, 1987
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)L K Kvols, M Buck, C G Moertel, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Cancer|March 1, 1976
A phase I study of cytembenaS Frytak, C G Moertel, A J Schutt, et al.
Journal of Surgical Oncology|July 1, 1982
Human colorectal carcinoma: patterns of sensitivity to chemotherapeutic agents in the human tumor stem cell assayM V Agrez, J S Kovach, R W Beart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinomaC G Moertel, D S Childs, J R O'Fallon, et al.
JAMA|February 13, 1981
A pharmacologic and toxicological study of amygdalinC G Moertel, M M Ames, J S Kovach, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987
Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy patternN A Scott, H S Wieand, C G Moertel, et al.
Cancer Clinical Trials|January 1, 1981
A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancerM J O'Connell, R E Ritts, C G Moertel, et al.
International Journal of Cancer|August 15, 1978
A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levelsA Shani, R E Ritts, G S Thynne, et al.
Cancer|June 1, 1979
A phase I study of chlorozotocin (NSC 178248)J S Kovach, C G Moertel, A J Schutt, et al.
The New England Journal of Medicine|September 27, 1979
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trialE T Creagan, C G Moertel, J R O'Fallon, et al.
Annals of Internal Medicine|August 1, 1987
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)L K Kvols, M Buck, C G Moertel, et al.
Pageof 15